Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations

The Biden administration says Medicare recipients will save about $1.5 billion dollars on medications to for diabetes, heart disease, types of arthritis and other ailments under new prices negotiated with drug companies that will take effect in 2026